Inotuzumab Ozogamicin OverviewInotuzumab ozogamicin (trade name Besponsa) is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The medication consists of the humanized monoclonal antibody against CD22 (inotuzumab), linked to a cytotoxic agent from the class of calicheamicins called ozogamicin. This drug was discovered by scientists collaborating at Celltech and Wyeth, and it was developed by Pfizer w...
Read more Inotuzumab Ozogamicin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Inotuzumab_ozogamicin
Recent Inotuzumab Ozogamicin Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Powder, For Injection Solution, Lyophilized Powder: 0.9/mg/vial
Other drugs which contain Inotuzumab Ozogamicin or a similar ingredient: (1 result)
- BESPONSA Inotuzumab Ozogamicin